Navigation Links
Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease
Date:7/30/2008

SAN FRANCISCO, July 30 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced new data showing that its investigational drug Dimebon continues to produce broad, clinically meaningful benefits in Alzheimer's disease patients after long-term dosing, and appears to operate through a novel mechanism of action. These data were presented today in a podium session and two poster sessions at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago. The presentations are highlighted below.

Dimebon Preserves All Key Functions in Alzheimer's Patients for 18 Months in Open-Label Extension of First Pivotal Trial

New data from a six-month open-label extension of the 12-month placebo-controlled study of Dimebon in patients with mild-to-moderate Alzheimer's disease demonstrated that Dimebon continued to improve the clinical course of the disease. After 18 months of treatment, Dimebon preserved function in patients at their original levels upon entering the trial across all key aspects of Alzheimer's disease, specifically memory and thinking, behavior, activities of daily living and overall function. These results are noteworthy as untreated Alzheimer's patients progressively deteriorate over time in these areas. Dimebon remained well tolerated throughout the 18-month treatment period.

The open-label extension data were presented in a poster session by Jeffrey Cummings, M.D., Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA. "To my knowledge, no other approved or investigational treatment has stabilized function across all facets of Alzheimer's disease for this length of time," said Dr. Cummings. "These data suggest that Dimebon may provide long
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
2. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
3. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
4. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
6. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
7. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
8. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
9. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
10. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
11. Anavex presents neuroprotective effects of Anavex 1-41 at the International Conference on Alzheimers Disease 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., NEW YORK, Nov. 20 Reportlinker...s available in its catalogue. ,, Pipettes &... http://www.reportlinker.com/p0164373/Pipettes--Pi...rce=prnewswire&utm_medium=pr&utm_campaign=...ted as an integral part of any research laboratory...
(Date:11/20/2009)... NATICK, Mass. and LONDON, Nov. 20 /PRNewswire-Fir...BSX ) today announced that it has received 510(k) ...on (FDA) and CE Mark approval to market its WallFl...eatment of malignant esophageal strictures (obstru...le or non-resectable esophageal cancer. ,, (Ph...
(Date:11/20/2009)...MPHIS, Tenn., Nov. 20 ...vision is pleased to announce the signing of a tec...s Department of Defense that may lead to the creat...lutionize the treatment of the limbs of soldiers w...the Defense Advanced Research Projects Agency (DAR...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients 60088 1Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients 60088 2Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients 60088 3Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients 60088 4Science at the petascale 3A Roadrunner results unveiled 60085 1Science at the petascale 3A Roadrunner results unveiled 60085 2Science at the petascale 3A Roadrunner results unveiled 60085 3Protein critical for insulin secretion may be contributor to diabetes 60082 1Protein critical for insulin secretion may be contributor to diabetes 60082 2Protein critical for insulin secretion may be contributor to diabetes 60082 3
(Date:11/22/2009)... The Onder Law Firm’s attorneys a...families of those who may have experienced heart a...er taking XOLAIR. , St. L...w Firm are among attorneys offering free XOLAIR c...art attack and stroke. The attorneys of the Onder...
(Date:11/22/2009)...v. 22 2009) -- Physician-scientists from Weill Cor...echanism that may prove to be a powerful target fo...of cancer that affects lymphocytes, or white blood...have been able to powerfully suppress tumor format...sing results have led to the design of a clinical ...
(Date:11/22/2009)... The holiday season is filled with get-...fun and joyous. It can also be stressful and tirin... stress, fatigue, and high fat foods -- factors th...hat,s why the National Foundation for Cancer Resea...can help ensure a happier, more healthful holiday ...
(Date:11/21/2009)...SHINGTON, Nov. 21 DNC C...fter the Senate voted to begin full debate of heal...tp://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO...c step on the road to enacting health insurance re...nators will now have an opportunity to debate the ...
(Date:11/21/2009)...ssociation Discusses Key Provisions of Legislation...m ,, ST. CHARLES, Ill., Nov. 21 /PRNewswire-US...ves passing the landmark Affordable Health Care fo...ey health reform legislation forward, Congress has...ealth care system. Today, AARP hosted an educatio...
Breaking Medicine News(10 mins):Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2
...ollowing high incidence of a potentially dangerous... lens solution, manufactured by Bausch & Lomb//, t...ted regarding the same and the controversial produ...le to claim that the product is safe to use. All u...
... new study indicates that people suffering from sy...ave decreased intake of vitamin C and manganese co...e written in the medical journal ‘Thorax’ by Dr N....led that the fruit consumption on an average was 1...
...s the indefinite strike by doctors belonging to fi..., hundreds of patients, especially from weaker sec...dicos denied treatment for them. Hospital gua...ep waiting for hours before going away disappointe...
...esearchers from Oxford University's Health Economi...e UK a staggering ?29 billion each year.// This is...get. The findings of the study are reported in the...ity and the rest in informal care. The report is b...
...he visiting Executive Director of United Nations P...angladesh has attained progress //in some sectors,...e health sector to become an advanced country. ...education and primary healthcare services Banglade...
... major concern for any mother with a child in day ...d with his daycare provider than with his mother./.../June issue of the journal Child Development shoul...ty of Dresden, all in Germany, and the University ...
Other Medicine News:Health News:Patients Bear The Brunt Of Doctor’s Strik 2Health News:Bangladesh Progressing But Must Yet Face Challenges In Health Sector 2Health News:Mamas Can Set Their Minds to Rest 2
...or 14 years -- and works! Baby Gender Mentor Home ...ng technology to attain the earliest gender detect... accuracy. The technique traces the amount of Y ch...ender. Here's how it works: Your baby releases its...
...luorescence in situ hybridization (FISH) assay des...ication in formalin-fixed, paraffin-embedded breas...etermined from the ratio between the number of sig... (red signals) and the number of signals from the ...
...se either the PARI LC PLUS® or PARI LC STAR&re...Maximize aerosol output when the patient inhales a...s using two one-way valves. Baffles allow particle...lt is a high percentage of particles in the respir...
..., ,ACE ensures prompt, effective delivery of aero...le design allows it to be used in a ventilator cir...r resuscitation bag and for routine, oral inhalati...centive spirometer to help teach the patient prope...
Medicine Products: